A nurse is caring for a client who has hypertension and nephropathy due to type 2 diabetes mellitus.The nurse should expect to administer which of the following medications to slow the progression of the nephropathy?

Choice A rationaleSitagliptin is a DPP-4 inhibitor used to manage blood glucose levels in type 2 diabetes. It does not have nephroprotective effects. It is not indicated for slowing the progression of diabetic nephropathy, which requires specific renal protective medications.Choice B rationaleGlipizide is a sulfonylurea that stimulates insulin secretion to lower blood glucose levels. It does not have nephroprotective properties. For patients with diabetic nephropathy, medications with renal benefits are preferred to slow disease progression.Choice C rationaleMetoprolol is a beta-blocker used to manage hypertension. While it controls blood pressure, it does not specifically target nephropathy progression. Other medications provide more direct renal protection in patients with diabetic nephropathy.Choice D rationaleLosartan is an angiotensin II receptor blocker (ARB) that helps manage hypertension and provides renal protection. ARBs reduce intraglomerular pressure, decreasing proteinuria and slowing nephropathy progression. It is beneficial in managing diabetic nephropathy. .